JPRN-UMIN000033786已完成未知
Outcomes of intravitreal aflibercept (Eylea) treatment for treatment-naive contralateral eyes with neovascular age-related macular degeneration in patients whose treatment failed intravitreal ranibizumab in the first eye - Fixed-Interval Versus As-Needed Dosing of Anti-Vascular Endothelial Growth Factor for Bilateral Neovascular Age-Related Macular Degeneration
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) patients with neovascularized maculopathies other than AMD, 2) patients with a history of prior photocoagulation, intravitreal anti-VEGF injection, photodynamic therapy, intravitreal or sub-tenon steroid injection, vitrectomy surgery, or intravitreal gas injection, 3) patients with diabetic retinopathy or retinal vein occlusion, and 4) patients with coexisting epiretinal membranes or vitreomacular traction syndrome.
研究者
相似试验
已完成
不适用
Outcomes of intravitreal aflibercept (Eylea®) treatment for treatment-naïve contralateral eyes with neovascular age-related macular degeneration in patients whose treatment failed with intravitreal ranibizumab in the first eyeDiseases of the eye and adnexaKCT0002448Seoul National University Hospital21
已完成
3 期
The efficacy of intravitreal aflibercept given in a ‘treat and extend’ regime in the treatment of cystoid macular oedema secondary to central retinal vein occlusion.central retinal vein occlusion (CRVO).cystoid macular oedemaEye - Diseases / disorders of the eyeACTRN12615000417583Centre for Eye Research Australia20
已完成
4 期
The study of Intravitreal aflibercept with treat and extend regimen for macular edema with branch retinal vein occlusion (BRVO)Branch retinal vein occlusionJPRN-UMIN000023200Department of Ophthalmology, Akita University50
已完成
不适用
Efficacy evaluation of intravitreal aflibercept for polypoidal choroidal vasculopathyJPRN-UMIN000010461Yokohama City University Medical Center30
已完成
不适用
ong term outcomes of intravitreous aflibercept injections for agerelated macular degeneratioAge-related macular degenerationJPRN-UMIN000024419Department of Ophthalmology Protective care for Sensory Disorders, Nagoya University Graduate School of Medicine120